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Expression of an alternate splice form of Bmi-1 in multiple myeloma 
The concept of “tumor stem cells” has garnered much attention in the last few 
years. Tumor stem cells are believed to exist among a heterogeneous group of 
cells that constitute a tumor.  These tumor stem cells often express genes that 
are important for stem cell function, cell division, and maintenance of pluripotent 
state in stem cells.  Stem cell or stem cell maintenance genes such as SALL 4 
and Bmi-1 are often seen in these cancer cells and contribute to self-renewing 
divisions and cancer cell survival. In particular, high expression of Bmi-1 (B 
lymphoma mouse Moloney leukemia virus insertion region), a member of the 
polycomb family of transcription factors, is often associated with poor prognosis 
in cancers.  
 
Our laboratory has shown the existence of an alternatively spliced Bmi-1 RNA 
and protein in multiple myeloma cells. The purpose of this research project is to 
understand the effect of an alternate splice form of Bmi-1 protein on cell cycle 
and apoptosis in multiple myeloma cells. To understand the effect of this 
alternate Bmi-1 protein, I first compared the growth rate of different myeloma cell 
lines and correlated that with the expression of the wild-type Bmi-1 and the 
alternatively spliced Bmi-1 form.  I performed time course experiments and 
counted the cell numbers in each cell line at various time points.  My results 
show that the myeloma cell lines, which highly express the alternate form of Bmi-
1, grew faster than the myeloma cell lines, which mostly express the wild-type 
form of Bmi-1.  Currently I am performing RT-PCR and western blot analysis to 
confirm the existence of the alternatively spliced Bmi-1 protein. I plan to isolate 
and sequence the alternatively spliced form of Bmi-1. I also plan to determine the 
effect of knocking-down Bmi-1 expression on cell cycle and apoptosis by 
incorporating inducible shRNA viral constructs targeted against Bmi-1 RNA in 
myeloma cells. 
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